Buy or sell Forty Seven stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Forty Seven Stock

Clinical-stage immuno-oncology company

About Forty Seven Stock

With a passion for pioneering breakthrough solutions, we are committed to the advancement of immuno-oncology through the engagement of new and complementary phagocytic pathways that enhance anti-tumor efficacy and selectivity.

Investors

Funding History

February 2016$75.0M

Management

Cofounder

Irving Weissman

Press

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Forty Seven or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Join 140K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo